Related Experiment Video

Updated: Jun 13, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Respiratory syncytial virus: immunopathology and control

Weidong Zhang1, Richard F Lockey, Shyam S Mohapatra

  • 1Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, University of South Florida, 12901 Bruce B. Downs Blvd., Tampa, FL 33612, USA. wzhang@hsc.usf.edu

Expert Review of Clinical Immunology
|May 19, 2010
PubMed

Insights

Respiratory syncytial virus (RSV) causes severe respiratory infections in children, potentially leading to asthma. Current vaccines are lacking, and understanding RSV immunity is crucial for developing effective prevention and treatment strategies.

Area of Science:

  • Virology
  • Immunology
  • Pediatrics

Background:

  • Respiratory syncytial virus (RSV) is a major global cause of infant respiratory infections.
  • RSV infection can predispose children to lifelong asthma and other health issues.
  • Existing vaccines against RSV are not yet available.

Purpose of the Study:

  • To review the current understanding of RSV infection biology and immunopathology.
  • To explore the roles of innate and adaptive immunity in RSV.
  • To discuss prophylactic and therapeutic strategies for controlling RSV.

Main Methods:

  • Literature review of RSV biology.
  • Analysis of immune responses to RSV infection.
  • Discussion of current and future control strategies.

Main Results:

  • RSV infection mechanisms and immunopathology are not fully understood.
  • Incomplete antiviral immunity leads to recurrent RSV infections throughout life.
  • Knowledge gaps in RSV immunity hinder vaccine development.

Conclusions:

  • Further research into RSV infection and immunity is essential.
  • Developing effective vaccines and treatments requires a deeper understanding of the immune response.
  • Prophylactic and therapeutic approaches are key to controlling RSV.

More Related Videos

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay

Published on: January 26, 2019

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...